1. Home
  2. ACXP vs OBAI Comparison

ACXP vs OBAI Comparison

Compare ACXP & OBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

SELL

Current Price

$1.04

Market Cap

5.8M

Sector

Health Care

ML Signal

SELL

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

HOLD

Current Price

$1.62

Market Cap

5.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACXP
OBAI
Founded
2017
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
5.4M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
ACXP
OBAI
Price
$1.04
$1.62
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $17.00
N/A
AVG Volume (30 Days)
84.4K
★ 167.0K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 40.53
EPS
N/A
★ N/A
Revenue
N/A
★ $9,972,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.34
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 2.42
52 Week Low
$0.95
$0.13
52 Week High
$7.54
$463.16

Technical Indicators

Market Signals
Indicator
ACXP
OBAI
Relative Strength Index (RSI) 40.18 40.98
Support Level N/A $0.13
Resistance Level $1.77 $2.48
Average True Range (ATR) 0.07 0.26
MACD 0.01 0.08
Stochastic Oscillator 48.53 7.03

Price Performance

Historical Comparison
ACXP
OBAI

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

Share on Social Networks: